According to the American Cancer Society, women diagnosed with stage-one breast disease have a 100% chance of survival. Yet in the United States, breast cancer is still the leading cause of cancer death among women between the ages of 20 and 59 and is the leading cause of cancer death for women worldwide.
Why? The most commonly used breast cancer screening methods are best at detecting mature cancers after years of growth and development. For patients with breast cancers identified in later stages, there are fewer treatment options and the survival rates are much lower.
The IMS breast cancer screening solution takes a different approach. By identifying and measuring metabolic changes in a patient’s physiology, Infrared Mammography can see the effects of breast cancers while they are still in their earliest stages of development. Detecting breast cancer earlier gives patients a life saving head start on the road to a cure.